Skip to content
ABMD Abiomed, Inc. BMV
7565.00 MXN 0.58% +43.66
OPEN 7565.00
PREV CLOSE 7521.34
DAY RANGE 7565.00 - 7565.00
52 WEEK RANGE 7565.00 - 4642.00
Interactive Brokers Logotype

Buy ABMD stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 341.1B
Enterprise value 6.3T
Trailing pe 2521.6666666667
Peg ratio -63.041666666667
Price to sales ttm 330.61685112619
Price to book mrq 213.20395550062
Enterprise to revenue 316.819
Enterprise to ebitda 1241.117


Fiscal year ends 2022-03-31
Most recent quarter 2022-09-30
Profit margin 0.24836001
Operating margin 0.22961001
Return on assets ttm 0.09554
Return on equity ttm 0.18244
Income statement
Revenue ttm 20B
Revenue per share ttm 23.609
Quarterly revenue growth 0.072
Gross profit ttm 15.7B
Ebitda 284.2M
Net income to common ttm 5B
Diluted eps ttm 115.45
Quarterly earnings growth yoy 0.864
Balance sheet
Total cash mrq 15.3B
Total cash per share mrq 18.194
Total debt to equity mrq 0.455
Current ratio mrq 7.928
Book value per share mrq 34.087
Cash flow
Operating cash flow ttm 4.7B
Levered free cash flow ttm 3.8B

Stock statistics

Shares outstanding 45.1M
Float shares 44.4M
Avg 10 volume 696
Avg 30 volume 958
Percent held by insiders 0.02024
Percent held by institutions 0.97089994

Stock price summary

Fifty two week high 7565
Fifty two week change 33.377
Beta 1.397629
Day 50 ma 6597.359
Day 200 ma 5862.0083

Dividends and splits

Abiomed (ABMD) company profile

Abiomed Inc. (NASDAQ: ABMD) is a research company that develops, manufactures, and markets cardiovascular products. The company’s products are designed to assist and replace the pumping function of the heart. Abiomed’s products and services are used by healthcare professionals on a global scale.